妇科恶性肿瘤手术患者静脉血栓栓塞的发生率及危险因素

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Istanbul Medical Journal Pub Date : 2023-05-31 DOI:10.4274/imj.galenos.2023.86143

H. Turan, I. Kahramanoglu, Ulviyya Alakbarova, Kubra Hamzaoglu, T. Beşe, M. Arvas, F. Demirkıran

{"title":"妇科恶性肿瘤手术患者静脉血栓栓塞的发生率及危险因素","authors":"H. Turan, I. Kahramanoglu, Ulviyya Alakbarova, Kubra Hamzaoglu, T. Beşe, M. Arvas, F. Demirkıran","doi":"10.4274/imj.galenos.2023.86143","DOIUrl":null,"url":null,"abstract":"933; p=0.039; OR: 0.002; 95% CI: 0.001-0.025; p=0.001; OR: 0.217; 95% CI: 0.082-0.577; p=0.002; OR: 0.033; 95% CI: 0.003-0.379; p=0.006, respectively]. Conclusion: We suggest that every patient undergoing gynecological oncology surgery should have preoperative pharmacological and postoperative extended dual prophylaxis to achieve the lowest incidence of VTE in this group.","PeriodicalId":42584,"journal":{"name":"Istanbul Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Incidence and Risk Factors of Venous Thromboembolism in Patients Undergoing Surgery for Gynecologic Malignancies\",\"authors\":\"H. Turan, I. Kahramanoglu, Ulviyya Alakbarova, Kubra Hamzaoglu, T. Beşe, M. Arvas, F. Demirkıran\",\"doi\":\"10.4274/imj.galenos.2023.86143\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"933; p=0.039; OR: 0.002; 95% CI: 0.001-0.025; p=0.001; OR: 0.217; 95% CI: 0.082-0.577; p=0.002; OR: 0.033; 95% CI: 0.003-0.379; p=0.006, respectively]. Conclusion: We suggest that every patient undergoing gynecological oncology surgery should have preoperative pharmacological and postoperative extended dual prophylaxis to achieve the lowest incidence of VTE in this group.\",\"PeriodicalId\":42584,\"journal\":{\"name\":\"Istanbul Medical Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Istanbul Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/imj.galenos.2023.86143\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Istanbul Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/imj.galenos.2023.86143","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

933；p=0.039；或：0.002；95%置信区间：0.001-0.025；p=0.001；或：0.217；95%置信区间：0.082-0.577；p=0.002；或：0.033；95%置信区间：0.003-0.379；p分别为0.006）。结论：我们建议每一位接受妇科肿瘤手术的患者都应该进行术前药物和术后扩展的双重预防，以实现该组VTE的最低发病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Incidence and Risk Factors of Venous Thromboembolism in Patients Undergoing Surgery for Gynecologic Malignancies

933; p=0.039; OR: 0.002; 95% CI: 0.001-0.025; p=0.001; OR: 0.217; 95% CI: 0.082-0.577; p=0.002; OR: 0.033; 95% CI: 0.003-0.379; p=0.006, respectively]. Conclusion: We suggest that every patient undergoing gynecological oncology surgery should have preoperative pharmacological and postoperative extended dual prophylaxis to achieve the lowest incidence of VTE in this group.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊